Contents

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Imaging neuroendocrine tumours of the gastrointestinal tract 

Imaging neuroendocrine tumours of the gastrointestinal tract
Chapter:
Imaging neuroendocrine tumours of the gastrointestinal tract
Author(s):

James E. Jackson

and Mary E. Roddie

DOI:
10.1093/med/9780199235292.003.0662
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 17 November 2019

Gastroenteropancreatic (GEP) tumours are best divided into two distinct groups when discussing their radiological imaging. First are the functioning insulinomas and gastrinomas, which are often small at presentation; imaging of these lesions is usually aimed at localization of the primary tumour (and exclusion of metastatic disease) with a view to surgical excision. Second are the nonfunctioning neoplasms and the functioning tumours—carcinoids being the most common—which secrete a variety of other hormones including glucagon, vasoactive intestinal polypeptide, 5-hydroxytryptamine, somatostatin, serotonin, and pancreatic polypeptide. These are often large at presentation and are, therefore, obvious on cross-sectional imaging studies or have already metastasized; the role of the radiologist in this group is usually that of documenting the extent of disease to guide operative or nonoperative therapy. These two groups will be discussed separately.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.